All In MedTech

Device Trial Radar · NCT02333864

POGO® Automatic Blood Glucose Monitoring System Clinical Study

Last checked: Nov 20, 2026Latest source record: May 28, 2015 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

287

Actual

Start

Dec 2014

Primary completion

Mar 2015

Study completion Mar 2015

Sponsor

Lead sponsor
Intuity Medical, IncNot on our public-company list
Sponsor type
Industry
First posted
Jan 7, 2015

More device trials from this sponsor

Design

Study type
Observational
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine if the POGO® system delivers accurate blood glucose readings in the hands of the lay user and assess the POGO® system accuracy when used by trained health care professionals.

Conditions

  • Diabetes Mellitus

Interventions

  • POGO® BGMSDevice

    SMBG

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Accuracy Validation of the POGO® BGMS: Minimum outcome of 95% of results within 20% of reference measurement.Time frame: Blood glucose measured at time of single visit for each subject, endpoint evaluated at completion of study (approximately four months after initiation.)

1 more outcomes with a free account

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Diablo Clinical Reasearch

    Walnut Creek, California

1 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.